Virtu Financial’s CorMedix CRMD Stock Holding History

Virtu Financial’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Buy	+15,418	New	+$122K	﹤0.01%	1069
2025 Q3	–	Sell	-22,708	Closed	-$280K	–	1564
2025 Q2	$280K	Buy	+22,708	New	+$251K	0.01%	779
2025 Q1	–	Sell	-18,419	Closed	-$149K	–	1469
2024 Q4	$149K	Buy	+18,419	New	+$184K	0.01%	950
2024 Q2	–	Sell	-10,797	Closed	-$46K	–	1401
2024 Q1	$46K	Sell	10,797 -16,582	-61%	-$57.5K	﹤0.01%	1039
2023 Q4	$103K	Buy	+27,379	New	+$94.2K	0.01%	1027
2022 Q2	–	Sell	-23,356	Closed	-$128K	–	1656
2022 Q1	$128K	Buy	+23,356	New	+$107K	0.01%	915
2021 Q3	–	Sell	-15,180	Closed	-$104K	–	1580
2021 Q2	$104K	Buy	+15,180	New	+$121K	0.01%	1197
2021 Q1	–	Sell	-34,230	Closed	-$254K	–	1659
2020 Q4	$254K	Buy	+34,230	New	+$233K	0.03%	727
2019 Q4	–	Sell	-47,291	Closed	-$302K	–	1499
2019 Q3	$302K	Buy	+47,291	New	+$397K	0.02%	753
2018 Q4	–	Sell	-78,810	Closed	-$382K	–	1617
2018 Q3	$382K	Buy	78,810 +41,220	+110%	+$101K	0.02%	718
2018 Q2	$45K	Buy	+37,590	New	+$43.5K	﹤0.01%	1774
2018 Q1	–	Sell	-45,350	Closed	-$114K	–	2044
2017 Q4	$114K	Buy	45,350 +25,322	+126%	+$72.7K	0.01%	1869
2017 Q3	$52K	Buy	+20,028	New	+$41.5K	﹤0.01%	2221

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Virtu Financial's CRMD Position: Q2 2026 in Review

Virtu Financial opened a new position in CorMedix (CRMD) in Q2 2026: 15,418 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #1069 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CRMD as recently as Q2 2025.

Virtu Financial first reported a position in CRMD in Q3 2017 and has held it in 13 quarters since. The position peaked at $382K in Q3 2018. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Virtu Financial held 15,418 shares of CorMedix worth $121K as of Q2 2026.
CorMedix was a new Virtu Financial position in Q2 2026.
CorMedix made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1069 holding.
Virtu Financial first reported a position in CorMedix in Q3 2017 and has held it in 13 quarters since.
Virtu Financial's CorMedix position peaked at $382K in Q3 2018.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.